COP vs FBRX · P/E 19, rev $34.92B vs $360.2M cap
ConocoPhillips (COP) versus Forte Biosciences Inc (FBRX) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan M. Lance.
Forte Biosciences Inc (FBRX) is a biotechnology company listed on NASDAQ.
Latest reported COP revenue for 2026-06-30 was $34.92B. Net income was $6.11B. COP currently screens at market cap $135.49B and trailing P/E 18.8.
FBRX does not have a complete income-statement cache yet.
COP currently screens at market cap $135.49B and trailing P/E 18.8. FBRX currently screens at market cap $360.2M.
Not investment advice. Open the COP and FBRX stock pages for the full models.
Not investment advice.